ARA 290 is a breakthrough therapeutic peptide designed to combat chronic inflammation and alleviate the symptoms of various conditions. This innovative product, derived from erythropoietin, works by targeting the innate repair receptor, offering a non-immunosuppressive approach to manage inflammatory diseases. ARA 290 demonstrates remarkable potential in addressing neuropathic pain, diabetic neuropathy, and other chronic inflammatory disorders. With its unique mechanism, it promotes tissue repair, reduces pain, and enhances overall well-being. Scientifically validated and with proven efficacy, ARA 290 stands as a promising solution for those